Table 1.
Characteristics of study participants (n = 38)
| Sex (n) | |
| Males | 32 |
| Females | 6 |
| Ethnicity (n) | |
| Caucasian | 35 |
| African | 2 |
| African-American | 1 |
| Mode of HIV infection (n) | |
| Heterosexual | 10 |
| MSMa | 38 |
| IVDUb | 0 |
| Age | 48.4 ± 9.2 (34-68)* |
| Years of known HIV infection | 11.9 ± 4.9 (4-21) |
| Years on ARV therapy | 7.7 ± 2.7 (3-16) |
| Years on didanosine and/or stavudine | 1.5 ± 2.3 (0-7) |
| Nadir CD4 count (106 cells/l) | 190 ± 188 (10-740) |
| Maximum HIV RNA (log copies/ml)C | 5.2 ± 0.6 (3.6-6.4) |
a MSM: males having sex with males; b IVDU: intra-venous drug users; c data only available for 30 patients
* Data expressed as mean ± SD (range)